tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Revenue

Compare
830 Followers

Ligand Pharma Revenue

Ligand Pharma had a revenue of 115.46M in the quarter ending Sep 30, 2025, with 142.43%. This bring the company's revenue in the last twelve months to 251.23M, Decreased 33.93%. In the fiscal year ending Dec 31, 2024, Ligand Pharma had annual revenue of 167.13M with 27.28% growth.
Revenue (ttm)
251.23M
Revenue Growth
64.83%
P/S Ratio
21.67
Revenue/Employee
$2,457,838
Employees
68
Market Cap
$3.62B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
167.13M35.82M+127.28%
Dec 31, 2023
131.31M-64.93M+66.91%
Dec 31, 2022
196.25M-45.30M+81.25%
Dec 31, 2021
241.54M77.98M+147.68%
Dec 31, 2020
163.56M43.28M+135.98%
Dec 31, 2019
120.28M-131.17M+47.83%
Dec 31, 2018
251.45M110.35M+178.21%
Dec 31, 2017
141.10M32.13M+129.48%
Dec 31, 2016
108.97M